LPC
Lion Point Capital Portfolio holdings
AUM
$16.7M
1-Year Est. Return
119.35%
This Fund
S&P 500
1 Year Est. Return
+119.35%
AUM
$16.7M
AUM Growth
-$2.59M
(-13%)
Holding
39
Top Sells
| 1 | +$391K | |
| 2 | +$375K | |
| 3 | +$141K | |
| 4 |
MRSN
Mersana Therapeutics
MRSN
|
+$2.89K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Seres Therapeutics
MCRB
$74M
| $280K | 1.67% |
31,570
|
|
||
27
Janux Therapeutics
JANX
$879M
| $264K | 1.58% |
19,000
|
|
||
28
uniQure
QURE
$1.78B
| $240K | 1.44% |
14,700
|
|
||
29
Regenxbio
RGNX
$369M
| $223K | 1.33% |
26,600
|
|
||
30
Azenta
AZTA
$1.07B
| $205K | 1.23% |
9,700
|
|
||
31
Innoviva
INVA
$1.59B
| $191K | 1.14% |
8,200
|
|
||
32
GH Research
GHRS
$1.7B
| $143K | 0.86% |
10,200
|
|
||
33
Arcutis Biotherapeutics
ARQT
$2.69B
| $124K | 0.74% |
5,250
|
|
||
|
IPHA
34
Innate Pharma
IPHA
$167M
| $104K | 0.62% |
81,151
|
|
||
|
SPRB
35
Spruce Biosciences
SPRB
$140M
| $65.3K | 0.39% |
1,000
|
|
||
|
DAWN
36
DELISTED
Day One Biopharmaceuticals
DAWN
| – | – |
-42,000
|
|
||
|
MRSN
37
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-100
|
|
||
38
Minerva Neurosciences
NERV
$225M
| – | – |
-35,000
|
|
||
|
VTYX
39
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-41,500
|
|